Status:
TERMINATED
A Trial of Infant Flow Biphasic Nasal Continuous Airway Pressure (NCPAP) Versus Infant Flow NCPAP for the Facilitation of Extubation in Infants </= 1250 Grams
Lead Sponsor:
Mount Sinai Hospital, Canada
Collaborating Sponsors:
The Physicians' Services Incorporated Foundation
Conditions:
Infant, Premature, Diseases
Bronchopulmonary Dysplasia
Eligibility:
All Genders
Up to 6 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to compare two methods of delivering Nasal Continuous Airway Pressure (NCPAP): Biphasic Mode and a continuous mode, to see which is better in getting babies off the ventil...
Detailed Description
Chronic lung disease (CLD) remains a significant problem among low birth weight infants with a reported incidence of up to 26% in infants \< 1500 grams. Nasal continuous positive airway pressure (NCPA...
Eligibility Criteria
Inclusion
- Infants \</= 1250 grams who are going to be extubated
Exclusion
- Congenital abnormalities of the upper airway
- Acquired nasal septum injury
- Congenital Heart Disease excluding Patent Ductus arteriosus
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT00308789
Start Date
April 1 2006
End Date
December 1 2009
Last Update
May 5 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
Toronto, Ontario, Canada, M5G1X5